Clinical trial
Influenza Vaccination in Prevention From Acute Coronary Events in Coronary…
NCT00371098 · National Institute of Cardiology, Warsaw, Poland, Other · Completed
Key facts
| NCT number | NCT00371098 |
|---|---|
| Title | Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study |
| Official title | Prospective, Randomized, Double-Blind Placebo Controlled Study on Influenza Vaccination in Prevention From Coronary Events in Patients With Coronary Artery Disease Confirmed by Angiography |
| Lead sponsor | National Institute of Cardiology, Warsaw, Poland, Other |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Biological |
| Interventions | Influenza vaccination: Influvac (SolvayPharma), placebo influenza vaccine |
| Enrollment | 658 |
| Start date | Oct 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Sep 1, 2006 |
| Last update posted | Oct 23, 2007 |
| Countries | Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: